RxDoctor Payments Data

Jennifer Seda Ramirez, MD

General Practice · St Augustine, FLNPI 1912971102

Payments from drug & device makers

$2,806in general payments, 2019–2025

Across 150 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$771
  • Novo Nordisk$663
  • AbbVie$527
  • Exact Sciences$156
  • Amgen$149
  • Abbott$70
  • plus $470 from 15 others

What the payments were for

  • Food & beverage$2,806100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,806 in reported general payments places this provider in the 90th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$103,918
Medicare patients
311
Services billed
1,188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide143$133,812
VraylarCariprazine Hcl48$75,585
EliquisApixaban67$74,078
XareltoRivaroxaban29$39,251
FarxigaDapagliflozin Propanediol28$34,619
Breztri AerosphereBudesonide/Glycopyr/Formoterol32$26,384
MounjaroTirzepatide21$24,699
JardianceEmpagliflozin23$23,823
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$16,369
JanuviaSitagliptin Phosphate19$15,506
Breo ElliptaFluticasone/Vilanterol29$11,864
LinzessLinaclotide15$8,474
Atrovent HfaIpratropium Bromide13$8,125
SymbicortBudesonide/Formoterol Fumarate17$5,579
Atorvastatin Calcium345$3,953

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$663$133,812143 claims
AbbVieVraylar, Linzess, Synthroid$527$85,96599 claims
PfizerEliquis$48$74,07867 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$771$66,58377 claims
Johnson & JohnsonXarelto$26$39,25129 claims
GSKTrelegy Ellipta, Breo Ellipta$61$28,23351 claims
Lilly USA, LLCMounjaro$51$24,69921 claims
Boehringer IngelheimJardiance$28$23,82323 claims
MerckJanuvia$14$15,50619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,901 general practice providers in Florida.

Other general practice in St Augustine

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →